The Ubiquitin Proteasome System and Muscle Development

Protein Degradation: Cell Biology of the Ubiquitin-Proteasome System

Volumn , Issue , 2007, Pages 21-47

  Kim, Johnny ^a   Hoppe, Thorsten ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Degeneration; E3 enzymes; Estruction; Muscle atrophy; Muscle development; Muscle Histology; MyoD; Myosin assembly; Organizing Muscle; Protein degradation; Regulatory factors; Ubiquitin proteasome System

Indexed keywords

EID: 84889445163     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527620227.ch2     Document Type: Chapter

References (134)

1. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J. Clin. Invest. 1996 Apr 1;97(7):1610-7.
2. Huang, J., and Forsberg, N.E. (1998). Role of calpain in skeletal-muscle protein degradation. Proc. Natl. Acad. Sci. U.S.A. 1998 Oct 13;95(21):12100-5.
3. Du, J., Wang, X., Miereles, C, Bailey, J.L., Debigare, R., Zheng, B., Price, S.R., and Mitch, W.E. (2004). Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest., 113. 115-123.
4. Lee, S.W., Dai, G., Hu, Z., Wang, X., Du, J., and Mitch, W.E. (2004). Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J. Am. Soc. Nephrol, 15. 1537-1545.
5. Lecker, S.H., Solomon, V., Mitch, W.E., and Goldberg, A.L. (1999). Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr., 129. 227S-237S.
6. Clark, K.A., McElhinny, A.S., Beckerle, M.C., and Gregorio, C.C. (2002). Striated muscle cytoarchitec-ture: an intricate web of form and function. Annu. Rev. Cell Dev. Biol., 18. 637-706.
7. Pownall, M.E., Gustafsson, M.K., and Emerson, CP., Jr. (2002). Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell Dev. Biol, Volume 18. 747-783.
8. Parker, M.H., Seale, P., and Rudnicki, M.A. (2003). Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat. Rev. Genet., vol. 4. 497-507.
9. Sabourin, L.A., and Rudnicki, M.A. (2000). The molecular regulation of myogenesis. Clin. Genet., 57. 16-25.
10. Davis, R.L., Weintraub, H., and Lassar, A.B. (1987). Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 51. 987-1000.
11. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T.K., Turner, D., Rupp, R., Hollenberg, S., and et al. eds. (1991). The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251(4995):761-6.
12. Choi, J., Costa, M.L., Mermelstein, C.S., Chagas, C., Holtzer, S., and Holtzer, H. (1990). MyoD converts primary dermal fibroblasts, chondro-blasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. USA, 87. 7988-7992.
13. Weintraub, H., Tapscott, S.J., Davis, R.L., Thayer, M.J., Adam, M.A., Lassar, A.B., and Miller, A.D. (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA, 86. 5434-5438.
14. Lassar, A.B., Paterson, B.M., and Weintraub, H. (1986). Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell, 47. 649-656.
15. Kltzmann, M., Carnac, G., Vandromme, M., Primig, M., Lamb, N.J., and Fernandez, A. (1998). The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J. Cell Biol., 142. 1447-1459.
16. Gardrat, F., Montel, V., Raymond, J., and Azanza, J.L. (1997). Proteasome and myogenesis. Mol. Biol. Rep., 24. 77-81.
17. Breitschopf, K., Bengal, E., Ziv, T., Admon, A., and Ciechanover, A. (1998). A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. Embo J, 17. 5964-5973.
18. Abu Hatoum, O., Gross-Mesilaty, S., Breitschopf, K., Hoffman, A., Gonen, H., Ciechanover, A., and Bengal, E. (1998). Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol. Cell Biol., 18. 5670-5677.
19. Varshavsky, A. (1997). The N-end rule pathway of protein degradation. Genes Cells, vol. 2. 13-28.
20. Batonnet, S., Leibovitch, M.P., Tintignac, L., and Leibovitch, S.A. (2004). Critical role for lysine 133 in the nuclear ubiquitin-mediated degradation of MyoD. J. Biol. Chem., 279. 5413-5420.
21. Lingbeck, J.M., Trausch-Azar, J.S., Ciechanover, A., and Schwartz, A.L. (2003). Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J. Biol. Chem., 278. 1817-1823.
22. Song, A., Wang, Q., Goebl, M.G., and Harrington, M.A. (1998). Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell Biol., 18. 4994-4999.
23. Ma, P.C., Rould, M.A., Weintraub, H., and Pabo, C.O. (1994). Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell, 77. 451-459.
24. Langlands, K., Yin, X., Anand, G., and Prochownik, E.V. (1997). Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J. Biol. Chem., 272. 19785-19793.
25. Lassar, A.B., Davis, R.L., Wright, W.E., Kadesch, T., Murre, G, Voronova, A., Baltimore, D., and Weintraub, H. (1991). Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell, 66. 305-315.
26. Kadesch, T. (1993). Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth Differ., 4. 49-55.
27. Sun, L., Trausch-Azar, J.S., Ciechanover, A., and Schwartz, A.L. (2005). Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation. J. Biol. Chem., 280. 26448-26456.
28. Lingbeck, J.M., Trausch-Azar, J.S., Ciechanover, A., and Schwartz, A.L. (2005). E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1. Oncogene.
29. Trausch-Azar, J.S., Lingbeck, J., Ciechanover, A., and Schwartz, A.L. (2004). Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD. J. Biol. Chem., 279. 32614-32619.
30. Murre, G, McCaw, P.S., Vaessin, H., Caudy, M., Jan, L.Y., Jan, Y.N., Cabrera, C.V., Buskin, J.N., Hauschka, S.D., Lassar, A.B. (1989). Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell, 58. 537-544.
31. Benezra, R., Davis, R.L., Lassar, A., Tapscott, S., Thayer, M., Lockshon, D., and Weintraub, H. (1990). Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann. NY Acad. Sci., 599. 1-11.
32. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L., and Weintraub, H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell, 61. 49-59.
33. Crescenzi, M., Fleming, T.P., Lassar, A.B., Weintraub, H., and Aaronson, S.A. (1990). MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA, 87. 8442-8446.
34. C. N. Larsen, H. Wang J. Proteome Res Rao, S.S., Chu, C., and Kohtz, D.S. (1994). Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell Biol., 14. 5259-5267.
35. Skapek, S.X., Rhee, J., Spicer, D.B., and Lassar, A.B. (1995). Inhibition of myogenic differentiation in proliferating myoblasts by cyclin Dl-dependent kinase. Science, 267. 1022-1024.
36. Kitzmann, M., Vandromme, M., Schaeffer, V., Carnac, G., Labbe, J.C., Lamb, N., and Fernandez, A. (1999). cdkl-and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell Biol., 19. 3167-3176.
37. Willems, A.R., Schwab, M., and Tyers, M. (2004). A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. BioPhys. Acta, 1695. 133-170.
38. Cardozo, T., and Pagano, M. (2004). The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol, 5. 739-751.
39. Tintignac, L.A., Leibovitch, M.P., Kitzmann, M., Fernandez, A., Ducommun, B., Meijer, L., and Leibovitch, S.A. (2000). Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp. Cell Res., 259. 300-307.
40. Tintignac, L.A., Sirri, V., Leibovitch, M.P., Lecluse, Y., Castedo, M., Metivier, D., Kroemer, G., and Leibovitch, S.A. (2004). Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol. Cell Biol., 24. 1809-1821.
41. Tintignac, L.A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M.P., and Leibovitch, S.A. (2005). Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J. Biol. Chem., 280. 2847-2856.
42. Skowyra, D., Craig, K.L., Tyers, M., Elledge, S.J., and Harper, J.W. (1997). F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell, 91. 209-219.
43. Yoshida, Y., Chiba, T., Tokunaga, F., Kawasaki, H., Iwai, K, Suzuki, T., Ito, Y., Matsuoka, K, Yoshida, M., Tanaka, K, and Tai, T. (2002). E3 ubiquitin ligase that recognizes sugar chains. Nature, 418. 438-442.
44. Ang, X.L., and Wade Harper, J. (2005). SCF-mediated protein degradation and cell cycle control. Oncogene, 24. 2860-2870.
45. Vandromme, M., Cavadore, J.C., Bonnieu, A., Froeschle, A., Lamb, N., and Fernandez, A. (1995). Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independently. Proc. Natl. Acad. Sci. USA, 92. 4646-4650.
46. Wojcik, C., and DeMartino, G.N. (2003). Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol., 35. 579-589.
47. De Conto, F., Missorini, S., Arcangeletti, C., Pinardi, F., Montarras, D., Pinset, C., Vassy, J., Geraud, G., Chezzi, C., and Scherrer, K. (1997). Prosome cytodistribution relative to desmin and actin filaments in dividing C2.7 myoblasts and during myotube formation in vitro. Exp. Cell Res., 233. 99-117.
48. Floyd, Z.E., Trausch-Azar, J.S., Reinstein, E., Ciechanover, A., and Schwartz, A.L. (2001). The nuclear ubiquitin-proteasome system degrades MyoD. J. Biol. Chem., 276. 22468-22475.
49. Lindon, C, Albagli, O., Domeyne, P., Montarras, D., and Pinset, C. (2000). Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol. Cell Biol., 20. 8923-8932.
50. Vinals, F., and Ventura, F. (2004). Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1 .J. Biol. Chem., 279. 45766-45772.
51. Heery, D.M., Hoare, S., Hussain, S., Parker, M.G., and Sheppard, H. (2001). Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J. Biol. Chem., 276. 6695-6702.
52. Nastasi, T., Bongiovanni, A., Campos, Y., Mann, L., Toy, J.N., Bostrom, J., Rottier, R., Hahn, C., Conaway, J.W., Harris, A.J., and D'Azzo, A. (2004). Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis. Dev. Cell, 6. 269-282.
53. Hoppe, T., Cassata, G., Barral, J.M., Springer, W., Hutagalung, A.H., Epstein, H.F., and Baumeister, R. (2004). Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. Cell, 118. 337-349.
54. Bienz, M., and Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell, 103. 311-320.
55. Gottardi, C.J., and Gumbiner, B.M. (2001). Adhesion signaling: how beta-catenin interacts with its partners. Curr. Biol., 11. R792-794.
56. Wu, G., Xu, G., Schulman, B.A., Jeffrey, P.D., Harper, J.W., and Pavletich, N.P. (2003). Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCPl) ubiquitin ligase. Mol. Cell, 11. 1445-1456.
57. Poiakis, P. (2002). Casein kinase 1: a Wnťer of disconnect. Curr. Biol., 12. R499-R501.
58. Matsuzawa, S.I., and Reed, J.C. (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell, 7. 915-926.
59. Liu, J., Stevens, J., Rote, C.A., Yost, H.J., Hu, Y., Neufeld, K.L., White, R.L., and Matsunami, N. (2001). Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell, 7. 927-936.
60. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H.E., Behrens, J., Sommer, T., and Birchmeier, W. (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol., 4. 222-231.
61. Kile, B.T., Schulman, B.A., Alexander, W.S., Nicoia, N.A., Martin, H.M., and Hilton, D.J. (2002). The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci, 27. 235-241.
62. Lai, E.C. (2002). Protein degradation: four E3s for the notch pathway. Curr. Biol., 12. R74-78.
63. Yeh, E., Dermer, M., Commisso, G, Zhou, L., McGlade, C.J., and Boulianne, G.L. (2001). Neuralized functions as an E3 ubiquitin ligase during Drosophila development. Curr. Biol., 11. 1675-1679.
64. Lai, E.C., Debiandre, G.A., Kintner, C., and Rubin, G.M. (2001). Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev. Cell, vol. 1. 783-794.
65. Wu, G., Liu, G, and He, X. (2004). Ozz; a new name on the long list of beta-catenin's nemeses. Mol. Cell, 13. 451-453.
66. Barral, J.M., Hutagalung, A.H., Brinker, A., Hartl, F.U., and Epstein, H.F. (2002). Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin. Science, 295, 669-671.
67. Hutagalung, A.H., Landsverk, M.L., Price, M.G., and Epstein, H.F. (2002). The UCS family of myosin chaperones, J. Cell Sci, 115, 3983-3990.
68. Epstein, H.F., and Thomson, J.N. (1974). Temperature-sensitive mutation affecting myofilament assembly in Caenorhabditis elegans. Nature, 250, 579-580.
69. Barral, J.M., Bauer, C.C., Ortiz, I., and Epstein, H.F. (1998). Unc-45 mutations in Caenorhabditis elegans implicate a CROl/She4p-like domain in myosin assembly. J. Cell Biol., 143, 1215-1225.
70. Hoppe, T., Cassata, G., Barral, J.M., Springer, W., Hutagalung, A.H., Epstein, H.F., and Baumeister, R. (2004). Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. Cell 118, 337-349.
71. Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U., and Jentsch, S. (1999). A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635-644.
72. Hoppe, T. (2005). Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Trends Biochem. Sci., 30, 183-187.
73. Cyr, D.M., Hohfeld, J., and Patterson, C. (2002). Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem. Sci., 27, 368-375.
74. Murata, S., Chiba, T., and Tanaka, K. (2003). CHIP: a quality-control E3 ligase collaborating with molecular chaperones. Int. J. Biochem. Cell Biol., 35, 572-578.
75. Ballinger, C.A., Connell, P., Wu, Y., Hu, Z., Thompson, L.J., Yin, L.Y., and Patterson, C. (1999). Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell Biol., 19, 4535-4545.
76. Price, M.G., Landsverk, M.L., Barral, J.M., and Epstein, H.F. (2002). Two mammalian UNC-45 isoforms are related to distinct cytoskeletal and muscle-specific functions, J. Cell Sci., 115, 4013-4023.
77. Kaneko, C, Hatakeyama, S., Matsumoto, M., Yada, M., Nakayama, K., and Nakayama, K.I. (2003). Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a. Biochem. Biophys. Res. Commun., 300, 297-304.
78. Mahoney, J.A., Odin, J.A., White, S.M., Shaffer, D., Koff, A., Casciola-Rosen, L., and Rosen, A. (2002). The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem. J. 361, 587-595.
79. Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S.R., Mitch, W.E., and Goldberg, A.L. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J. 18, 39-51.
80. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N., and Nakayama, K.I. (2001). U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem., 276, 33111-33120.
81. Jiang, J., Ballinger, C.A., Wu, Y., Dai, Q., Cyr, D.M., Hohfeld, J., and Patterson, C. (2001). CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem., 276, 42938-42944.
82. Murata, S., Minami, Y., Minami, M., Chiba, T., and Tanaka, K. (2001). CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep., 2, 1133-1138.
83. Furuno, K, and Goldberg, A.L. (1986). The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism. Biochem. J, 237. 859-864.
84. Medina, R., Wing, S.S., and Goldberg, A.L. (1995). Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J, 307 (Pt 3). 631-637.
85. Wing, S.S., and Banville, D. (1994). 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am. J. Physiol, 267. E39-48.
86. Fischer, D., Sun, X., Gang, G., Pritts, T., and Fiasselgren, P.O. (2000). The gene expression of ubiquitin ligase E3alpha is upregu-lated in skeletal muscle during sepsis in rats-potential role of glucocorticoids. Biochem. Biophys. Res. Commun., 267. 504-508.
87. Lecker, S.FT, Solomon, V., Price, S.R., Kwon, Y.T., Mitch, W.E., and Goldberg, A.L. (1999). Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J. Clin. Invest., 104. 1411-1420.
88. Solomon, V., Baracos, V., Sarraf, P., and Goldberg, A.L. (1998). Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. Proc. Natl. Acad. Sci. USA, 95. 12602-12607.
89. Kwak, K.S., Zhou, X., Solomon, V., Baracos, V.E., Davis, J., Bannon, A.W., Boyle, W.J., Lacey, D.L., and Han, H.Q. (2004). Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia. Cancer Res., 64. 8193-8198.
90. Koohmaraie, M. (1992). The role of Ca(2+)-dependent proteases (calpains) in post mortem proteolysis and meat tenderness. Biochimie, 74. 239-245.
91. Solomon, V., and Goldberg, A.L. (1996). Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem., 271. 26690-26697.
92. Williams, A., Sun, X., Fischer, J.E., and Hasselgren, P.O. (1999). The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery, 126. 744-749; discussion 749-750.
93. Taillandier, D., Aurousseau, E., Meynial-Denis, D., Bechet, D., Ferrara, M., Cottin, P., Ducastaing, A., Bigard, X., Guezennec, C.Y., Schmid, H.P. (1996). Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem. J., 316 (Pt 1). 65-72.
94. Ditzel, M., Wilson, R., Tenev, T., Zachariou, A., Paul, A., Deas, E., and Meier, P. (2003). Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat. Cell Biol., 5. 467-473.
95. Ditzel, M., and Meier, P. (2005). Ubiquitylation in apoptosis: DIAPl's (N-)en(d)igma. Cell Death Differ., 12. 1208-1212.
96. Moretti, A., Weig, H.J., Ott, T., Seyfarth, M., Holthoff, H.P., Grewe, D., Gillitzer, A., Bott-Flugel, L., Schomig, A., Ungerer, M., and Laugwitz, K.L. (2002). Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc. Natl. Acad. Sci. USA, 99. 11860-11865.
97. Du, J., Wang, X., Miereles, G, Bailey, J.L., Debigare, R., Zheng, B., Price, S.R., and Mitch, W.E. (2004). Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest., 113. 115-123.
98. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K., Pan, Z.Q., Valenzuela, D.M., DeChiara, T.M., Stitt, T.N., Yancopoulos, G.D., and Glass, D.J. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294. 1704-1708.
99. Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S.R., Mitch, W.E., and Goldberg, A.L. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J., 18. 39-51.
100. Nikawa, T., Ishidoh, K., Hirasaka, K., Ishihara, I., Ikemoto, M., Kano, M., Kominami, E., Nonaka, I., Ogawa, T., Adams, G.R., Baldwin, K.M., Yasui, N., Kishi, K., and Takeda, S. (2004). Skeletal muscle gene expression in space-flown rats. Faseb J., 18. 522-524.
101. Centner, T., Yano, J., Kimura, E., McElhinny, A.S., Pelin, K., Witt, C.C., Bang, M.L., Trombitas, K., Granzier, H., Gregorio, C.C., Sorimachi, H., and Labeit, S. (2001). Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J. Mol. Biol., 306. 717-726.
102. Pizon, V., Iakovenko, A., Van Der Ven, P.F., Kelly, R., Fatu, G, Furst, D.O., Karsenti, E., and Gautel, M. (2002). Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J. Cell Sci., 115. 4469-4482.
103. McElhinny, A.S., Perry, C.N., Witt, C.C., Labeit, S., and Gregorio, C.C. (2004). Muscle-specific RING finger-2 (MURF-2) is important for microtubule, intermediate filament and sarcomeric M-line maintenance in striated muscle development. J. Cell Sci., 117. 3175-3188.
104. Spencer, J.A., Eliazer, S., Iiaria, R.L., Jr., Richardson, J.A., and Olson, E.N. (2000). Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J. Cell Biol., 150. 771-784.
105. McElhinny, A.S., Kakinuma, K, Sorimachi, H., Labeit, S., and Gregorio, C.C. (2002). Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1, I. Cell Biol., 157. 125-136.
106. Dai, K.S., and Liew, C.C. (2001). A novel human striated muscle RING zinc finger protein, SMRZ, interacts with SMT3b via its RING domain. J. Biol. Chem., 276. 23992-23999.
107. Kedar, V., McDonough, H., Arya, R., Li, H.H., Rockman, H.A., and Patterson, C. (2004). Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I Proc. Natl. Acad, Sci. USA, 101. 18135-18140.
108. Witt, S.H., Granzier, H., Witt, C.C. and Labeit, S. (2005). MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol., 350. 713-722.
109. Tskhovrebova, L., and Trinick, J. (2003). Titin: properties and family relationships. Nat. Rev. Mol. Cell Biol., vol. 4. 679-689.
110. Kramerova, I., Kudryashova, E., Tidball, J.G., and Spencer, M.J. (2004). Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet., 13. 1373-1388.
111. Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A., and Goldberg, A.L. (2001). Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad, Sci. USA, 98. 14440-14445.
112. Jagoe, R.T., Lecker, S.H., Gomes, M.. and Goldberg, A.L. (2002). Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. Faseb J., 16. 1697-1712.
113. Wray, C.J., Mammen, J.M., Hershko, D.D., and Hasselgren, P.O. (2003). Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int. J. Biochem. Cell Biol., 35. 698-705.
114. Dehoux, M.J., van Beneden, R.P., Fernandez-Celemin, L., Lause, P.L., and Thissen, J.P. (2003). Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett., 544. 214-217.
115. Sandri, M., Sandri, G, Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K, Schiaffino, S., Lecker, S.H., and Goldberg, A.L. (2004). Fox(transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117. 399-412.
116. Doyle, D.A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon, R. (1996). Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell, 85. 1067-1076.
117. Stitt, T.N., Dru;an, D., Ciarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., Gonzalez, M., Yancopoulos, G.D., and Glass, D.J. (2004). The IGF-1/P13K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell, 14. 395-403.
118. Cao, P.R., Kim, H.J., and Lecker, S.H. (2005). Ubiquitin-protein ligases in muscle wasting. Int. J. Biochem. Cell Biol., 37. 2088-2097.
119. Li, H.H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.Z., and Patterson, C. (2004). Atrogin-l/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest., 114. 1058-1071.
120. Serrano, A.L., Murgia, M., Pallafacchina, G., Calabria, E., Coniglio, P., Lomo, T., and Schiaffino, S. (2001). Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth. Proc. Natl. Acad. Sci. USA, 98. 13108-13113.
121. Marinovic, A.C., Zheng, B., Mitch, W.E., and Price, S.R. (2002). Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J. Biol. Chem., 277. 16673-16681.
122. Dardevet, D., Sornet, C., Vary, T., and Grizard, J. (1996). Phosphati-dylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology, 137. 4087-4094.
123. Price, S.R., Bailey, J.L., Wang, X., Jurkovitz, C., Engiand, B.K, Ding, X., Phillips, L.S., and Mitch, W.E. (1996). Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest., 98. 1703-1708.
124. Mitch, W.E., and Price, S.R. (2001). Mechanisms activated by kidney disease and the loss of muscle mass. Am.J, Kidney Dis., 38. 1337-1342.
125. Kwon, Y.T., Xia, Z., Davydov, I.V., Lecker, S.H., and Varshavsky, A. (2001). Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway. Mol. Cell Biol., 21. 8007-8021.
126. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A.M., Andersen, J. S., Mann, M., Mercurio, F., and Ben-Neriah, Y. (1998). Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature, 396. 590-594.
127. Chen, Z.J. (2005). Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol., 7. 758-765.
128. Cai, D., Frantz, J.D., Tawa, N.E., Jr., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J., and Shoelson, S.E. (2004). IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell, 119. 285-298.
129. Whitehouse, A.S., Khal, J., and Tisdale, M.J. (2003). Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway. Br. J. Cancer, 89. 737-745.
130. Li, Y.P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D.L., and Reid, M.B. (2005). TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atroginl/MAFbx in skeletal muscle. Faseb J., 19. 362-370.
131. Tracey, K.J. (2002). Lethal weight loss: the focus shifts to signal transduction. Sci. STKE, 2002. PE21.
132. Koistinen, H.A., Chibalin, A.V., and Zierath, J.R. (2003). Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia, 46. 1324-1328.
133. Williamson, D., Gallagher, P., Harber, M., Hollon, C., and Trappe, S. (2003). Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J. Physiol, 547. 977-987.
134. Di Giovanni, S., Molon, A., Broccolini, A., Melcon, G., Mirabella, M., Hoeeman, E.P., and Servidei, S. (2004). Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann. Neurol, 55. 195-206.